You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

16 Results
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
May 2022
Drug
Other Name(s): Xgeva®; Wyost™
Oct 2024
Drug
Other Name(s): Agrylin®
Apr 2024
Drug
Other Name(s): Revlimid®
Mar 2024

Pages